FibroBiologics gets new U.S. patent covering fibroblast wound-healing therapy
FibroBiologics said a newly issued U.S. patent covers topical administration of 3D spheroid fibroblasts and fibroblast-derived materials to treat and accelerate healing of wounds.
Newly Issued Patent Covers Topical Administration of 3D Spheroid Fibroblasts and Fibroblast-Derived Materials to Treat and Accelerate the Healing of WoundsHOUSTON, Sept.
3, 2026 // -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270…